Publication | Open Access
Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer
34
Citations
43
References
2019
Year
Identification of potential predictive markers, resistance mechanisms and rational combination therapies could be achieved by applying a CRISPR-dCas9 screening approach in bladder cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1